Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Arthrotec 50 Modified Release Tablet – PA0822/112/001
- Genotropin 12mg Powder and Solvent for solution for Injection – PA0822/128/002
- Halcion 125mg Tablet – PA0822/129/002
- Hypnovel 10mg/5ml Solution for Injection – PA2239/007/002
- Novolizer Budesonide 200mcg Inhalation Powder – PA2010/032/001
- Novolizer Salbutamol 100mcg Inhalation Powder – PA2010/033/001
- Sirdupla 25mcg/125mcg per dose Pressurised Inhalation Suspension – PA0577/201/001
- Sirdupla 25mcg/250mcg per dose Pressurised Inhalation Suspension – PA0577/201/002
- Venlafaxine XL 37.5mg Prolonged Release Capsule – PA1347/036/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Celebrex 200mg Capsule – PA0822/116/002
- Ciprofloxacin 500mg Teva Film Coated Tablet – PA0749/031/003
- Cozaar Comp 100mg/12.5mg Film Coated Tablet – PA1286/001/001
- Epanutin 50mg Capsule – PA0822/011/002
- Flixotide 125mcg Evohaler – PA1077/044/014
- Lopid 300mg Capsule – PA0822/014/001
- Tamoxifen 20mg Tablet – PA0577/207/001
- Trandate 5mg/ml Solution for injection – PA1638/006/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.